[%TAGS (074db819ec% %074db819ec) %]
(074db819ec% IF user.email && action == 'arc' %074db819ec)
(074db819ec% END %074db819ec)
- From: "Carlos Horkan" <CarlosH@henrystewart.co.uk>
- To: "Gerben Gieling" <Gerben.Gieling@synthon.nl>, "Roland Orre" <orre@nada.kth.se>, "PILCH Hartmut" <phm@a2e.de>
- Cc: <epo@mlist.austria.eu.net>, <patents@aful.org>, <intprop-l@topica.com>, <horns@ipjur.com>
- Subject: [Patents] epoline file inspection not working
- Date: Mon, 10 Feb 2003 12:58:06 -0000
Dear Sir/Madam
I have a question. I am organising a 1-day event on the 20th February and I
am trying to reach as many law firms as possible who may have an interest in
this area. Can anyone tell me the best way in which to do this.
Yours sincerely
Dr Carlos Horkan
Title: Defending Value and Maximising Profitability of Innovative
Pharmaceuticals over their Entire Life Cycles
Date: Thursday, 20th February 2003
Venue: Radisson Portman Hotel, London
Optimising the patent grant and constructing interlocking patent protection
strategies
Warding off challenges
Ensuring effective enforcement
Maximising extension of exclusivity
Managing the transition to post patent marketing
Chairman
Michael Burdon, Partner, Head of Biosciences Group, Olswang
Speaker Faculty
Adam Barak, Director, ABPPC Ltd
Richard Eggleston, Research and Development Director, Galpharm Healthcare
Dr Jonathan K. Embleton, Vice President, Business Development, Cardinal
Health (Europe), Switzerland
Julian Hitchcock, Eversheds 'Biosciences' Group
Michael Hutchins, Patent Attorney, M.R. Hutchins & Co
Morag Macdonald, Partner, Bird & Bird
Paul Ranson, Consultant, Stringer Saul
Nigel Stoate, Taylor Wessing
Full conference detail can be found at
http://www.henrystewart.com/conferences/february2003/N02615/index.html
Alternatively, please contact Dr Carlos Horkan on +44 207 404 3040 (Email;
Carlosh@henrystewart.co.uk)
(074db819ec%|loc%074db819ec)Archive powered by(074db819ec%END%074db819ec) MhonArc 2.6.16.
(074db819ec%TAGS [% %]%074db819ec)